Compound ID | 848
Class: Streptogramin
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Haemophilus influenzae and Staphylococcus aureus |
| Description: | Sabath L.D., Liebeler C and Kelly J. Antistaphylococcal activity of RPR 106972 (RPR 112808/RPR106950), a new oral streptogramin compared with that of twelve other antimicrobial agents. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995;132 |
| Institute where first reported: | Sanofi Aventis, France |
| Year first mentioned: | 1995 |
| Highest development stage: | Phase 2 |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5748661 |
| Guide to Pharmacology: | efepristin |
| Citation: | https://doi.org/10.1016/S0732-8893(97)00023-0 |